Home » Topics » BioWorld Science

BioWorld Science
RSS

Esteve Pharmaceuticals presents new analgesic drugs

Aug. 20, 2021

CAR T-cell therapy enters first-in-human trial for hematologic cancers

Aug. 20, 2021

Vigil Neuroscience advances TREM2 agonists

Aug. 20, 2021

Persica completes first stage of clinical trial on PP-353 for low back pain

Aug. 20, 2021

Bright Minds Biosciences compound reduces seizures in animal models of Dravet syndrome/epilepsy

Aug. 20, 2021

COM-902 derivative AZD-2936 enters the clinic for non-small cell lung cancer

Aug. 19, 2021

Well Marker Bio starts phase I study of WM-S1-030 for solid tumors

Aug. 19, 2021

"Not just the flu" holds for SARS-CoV-2 long-term effects, too

Aug. 19, 2021

TT-00420 enters phase I/II trial for advanced solid tumors

Aug. 19, 2021

Viral-trapping icosahedral shells devised as broad-spectrum antiviral platform

Aug. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...